• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News

    GAVI Unveils New Vaccine Price Reduction Deals

    By Ivy Mungcal // 07 June 2011
    A man takes out yellow fever vaccines from its box. Photo by: Olivier Asselin / GAVI

    The Global Alliance for Vaccines and Immunization said June 6 that it had secured commitments from four pharmaceutical companies to lower prices of the vaccines they manufacture.

    GAVI said Panacea Biotec had committed to cut down its prices by up to 15 percent, while Serum Institute, which had already reduced its prices to $1.75 per dose, had pledged to continue providing the most competitive pricing for the pentavalent vaccine, which can protect against diphtheria, pertussis, tetanus, hepatitis B, and Haemophilus influenzae type b.

    GlaxoSmithKline had also offered to provide its rotavirus vaccine to GAVI at $2.50 per dose, some 67 percent lower than the current lowest available price, while Merck had pledged to offer its rotavirus vaccine to UNICEF at reduced prices, GAVI said.

    “These are promising offers that demonstrate industry commitment to work towards affordable and sustainable prices for life-saving vaccines in developing countries. We congratulate all manufacturers who have responded to our call in the lead up to the pledging conference,” GAVI interim head Helen Evans said in a statement.

    GAVI is holding a pledging conference in the United Kingdom on June 13, with an eye on raising up to $3.7 billion.

    >> GAVI’s 2011 Pledging Conference Set for June 13

    Read more development aid news.

    • Global Health
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Ivy Mungcal

      Ivy Mungcal

      As former senior staff writer, Ivy Mungcal contributed to several Devex publications. Her focus is on breaking news, and in particular on global aid reform and trends in the United States, Europe, the Caribbean, and the Americas. Before joining Devex in 2009, Ivy produced specialized content for U.S. and U.K.-based business websites.

    Search for articles

    Related Stories

    MalariaPrice of first malaria vaccine to be slashed by more than half

    Price of first malaria vaccine to be slashed by more than half

    Global HealthRobert F. Kennedy Jr. says the US is cutting funding for Gavi

    Robert F. Kennedy Jr. says the US is cutting funding for Gavi

    Global HealthGavi pledges fall short about $2.9B as US pulls out

    Gavi pledges fall short about $2.9B as US pulls out

    Global healthHow Gavi is reaching ‘zero-dose’ children in conflict areas

    How Gavi is reaching ‘zero-dose’ children in conflict areas

    Most Read

    • 1
      How to use law to strengthen public health advocacy
    • 2
      Lasting nutrition and food security needs new funding — and new systems
    • 3
      House cuts US global education funding 20%, spares multilateral partners
    • 4
      The power of diagnostics to improve mental health
    • 5
      Opinion: The pursuit of remission — from possibility to priority
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement